European Pharmaceutical Review

SEPTEMBER 22, 2023

Active anti-Abeta immunotherapies In the 2000s, the concept of active immunotherapy targeting Abeta in Alzheimer’s patients was assessed with the ELAN vaccine (AN1792), consisting of full-length aggregated Abeta 1-42 peptide mixed with the QS21 adjuvant. 8 However, as this trial was not placebo-controlled, conclusions are difficult to draw.

Immunity 97

Immunity Immunization Vaccines Communication 97

pharmaphorum

FEBRUARY 26, 2021

The company has also faced claims that it did not adequately communicate the risks of its opioid painkillers in its marketing, contributing to the US’ ‘opioid epidemic’, and that its talc products could contain small amounts of asbestos and lead to cancer. Litigation & controversy. CEO Alex Gorsky, who was appointed in 2012.

Vaccines 126

Vaccines Biosimilars Labelling Communication 126

pharmaphorum

DECEMBER 22, 2022

She also mentioned, “vaccines before cancer even presents, before the massively hostile tumour environment”. There are persistent discrepancies, she said, between women, elderly people, minor ethnic and racial backgrounds, and marginalised communities, all disadvantaged in different ways: more than enough reason to focus on inequalities.

Vaccines 98

Vaccines Communication 98